Cargando…
PPARγ-K107 SUMOylation regulates insulin sensitivity but not adiposity in mice
The nuclear receptor peroxisome proliferator-activated receptor γ (PPARγ) is a master regulator of adipocyte differentiation and is the target for the insulin-sensitizing thiazolidinedione (TZD) drugs used to treat type 2 diabetes. In cell-based in vitro studies, the transcriptional activity of PPAR...
Autores principales: | Katafuchi, Takeshi, Holland, William L., Kollipara, Rahul K., Kittler, Ralf, Mangelsdorf, David J., Kliewer, Steven A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275522/ https://www.ncbi.nlm.nih.gov/pubmed/30420515 http://dx.doi.org/10.1073/pnas.1814522115 |
Ejemplares similares
-
An integrated functional genomic analysis identifies the antitumorigenic mechanism of action for PPARγ in lung cancer cells
por: Kollipara, Rahul K., et al.
Publicado: (2014) -
PPARγ sumoylation-mediated lipid accumulation in lung cancer
por: Phan, Ai N.H., et al.
Publicado: (2017) -
Correction: PPARγ sumoylation-mediated lipid accumulation in lung cancer
por: Phan, Ai N.H., et al.
Publicado: (2019) -
Crocin Improves Insulin Sensitivity and Ameliorates Adiposity by Regulating AMPK-CDK5-PPARγ Signaling
por: Fang, Kai, et al.
Publicado: (2020) -
Cross-Talk between PPARγ and Insulin Signaling and Modulation of Insulin Sensitivity
por: Leonardini, Anna, et al.
Publicado: (2009)